Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-12-000709
Filing Date
2012-05-15
Accepted
2012-05-15 12:38:10
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 flph10qmar312012.htm 10-Q 1014076
2 ex31-1.htm EX-31.1 16615
3 ex32-1.htm EX-32.1 5704
  Complete submission text file 0001415889-12-000709.txt   2806530

Data Files

Seq Description Document Type Size
4 fpmi-20120331.xsd EX-101.SCH 29674
5 fpmi-20120331.xml EX-101.INS 303150
6 fpmi-20120331_pre.xml EX-101.PRE 93117
7 fpmi-20120331_lab.xml EX-101.LAB 147707
8 fpmi-20120331_def.xml EX-101.DEF 31742
9 fpmi-20120331_cal.xml EX-101.CAL 30611
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 02116
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 02116 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

EIN.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-147193 | Film No.: 12842606
SIC: 2835 In Vitro & In Vivo Diagnostic Substances